Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion

Abstract

John Hall Alimera Sciences Ltd., Aldershot, Hampshire, UKI read “Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion” published in May 2016 by Sobha Sivaprasad and Sesan Oyetunde. The article is extremely important as it explains why short- and long-acting corticosteroids are so important in reducing intravitreal injections in clinic practices and the number of visits to the clinic. The authors present a valid point that this can be achieved with no impact on visual outcomes in diabetic macular edema (DME) and retinal vein occlusion. However, having read the article in detail, I would like to raise two important oversights that the authors have failed to address and are potentially misleading, and these are highlighted in the following section.View the original paper by Sivaprasad and Oytunde.

Keywords

• Diabetic macular edema
• fluocinolone
• intravitreal injections